Bandingkan Harga & Kinerja Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Panca Global Kapital Tbk. (PEGE)

Brigit Biofarmaka Teknologi Tbk.Trading

Panca Global Kapital Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Panca Global Kapital Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Panca Global Kapital Tbk. diperdagangkan di Rp130 (kapitalisasi pasar 487,35 M, volume 24 jam 11,11 jt). Perbedaan utamanya: Panca Global Kapital Tbk. jauh lebih besar — sekitar 2,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Panca Global Kapital Tbk. lebih aktif diperdagangkan (11,11 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.

	OBAT	PEGE
Kapitalisasi Pasar	166,01 M	487,35 M
Volume	324 rb	11,11 jt
Lot	3,24 rb	111,15 rb
Perputaran	77,68 jt	1,42 M
Harga Rata-rata	239,75	127,8
Nilai Transaksi	77,68 jt	1,42 M
Harga Ekuilibrium Indikatif	240	130
Volume Ekuilibrium Indikatif	1	1,46 rb

Lihat detail →Lihat detail →

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

OBAT

Lihat detail →

PEGE

Lihat detail →

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT →

Tentang Panca Global Kapital Tbk.

PT Panca Global Securities Tbk. (the Company) was established based on notarial deed No. 20 dated August 13th, 1999 of Fathiah Helmi, S.H., notary in Jakarta. The company's articles of association has been amended several times, and the latest amended on August 30, 2004 concerning company's plan for public offering. The company divides business into 2 divisions, stock brokerage and investment management division.

Selengkapnya di halaman PEGE →